SORT BY:     Most Recent      Most Viewed
  • November 1, 2007

    The American College of Physicians (ACP) has published new advice to clinicians regarding the diagnosis and management of chronic obstructive pulmonary disease (COPD) in adults.

  • September 1, 2007

    Chronic obstructive pulmonary disease (COPD) affects 10.1% of people worldwide and has been linked to passive smoke exposure, according to a new analysis. In addition, poor airway function in...

  • July 1, 2007

    Results of a clinical trial and a systematic review of varenicline (Chantix—Pfizer) confirm its safety and efficacy for smoking cessation in doses of 1 mg twice daily for up to 52 weeks....

  • March 1, 2007

    Branded albuterol inhalers containing the newer and more environmentally friendly propellant hydrofluoroalkane (HFA) are as safe and effective as generic inhalers that contain the propellant...

  • September 1, 2006

    Two novel alternatives for smoking cessation— the recently approved nicotinic activator varenicline (Chantix—Pfizer) and a related drug, cytisine (Tabex—Sopharma JSCo), used commonly in Eastern...